{"id":515099,"date":"2026-06-23T22:59:24","date_gmt":"2026-06-23T22:59:24","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/515099\/"},"modified":"2026-06-23T22:59:24","modified_gmt":"2026-06-23T22:59:24","slug":"glaucoma-risk-higher-among-women-with-postmenopausal-hrt","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/515099\/","title":{"rendered":"Glaucoma risk higher among women with postmenopausal HRT"},"content":{"rendered":"<p>A <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.70138\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">recent population-based study<\/a> published in Acta Ophthalmologica evaluated the potential link between postmenopausal hormone replacement therapy (<a href=\"https:\/\/www.nhs.uk\/medicines\/hormone-replacement-therapy-hrt\/\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">HRT<\/a>) and eye health\u2014specifically the incidence of glaucoma.<\/p>\n<p>I have to ask \u2026 why look at this possible connection?<\/p>\n<p>While postmenopausal <a href=\"https:\/\/www.nhs.uk\/medicines\/hormone-replacement-therapy-hrt\/\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">HRT<\/a> has been widely used to manage symptoms like hot flashes and bone loss, its role in eye health has remained less clear.<\/p>\n<p>The challenge is that hormone therapy isn\u2019t a single, uniform exposure. It varies widely in formulation, dosing, duration, and timing relative to menopause, all of which can influence how it affects ocular tissues.<\/p>\n<p>As a result, <a href=\"https:\/\/e-jmm.org\/DOIx.php?id=10.6118\/jmm.25108\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">studies<\/a> have reported mixed results based on these differences in exposure and patient populations.In fact, some <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1350946225000096\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">earlier research<\/a> has suggested that estrogen might help protect the optic nerve, with evidence linking estrogen to retinal ganglion cell (RGC) survival and intraocular pressure (IOP) regulationAnd <a href=\"https:\/\/e-jmm.org\/DOIx.php?id=10.6118\/jmm.25108\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">other findings<\/a> have pointed toward increased or variable risk depending on how hormone therapy is used.Go on \u2026<\/p>\n<p>That variability makes it difficult to compare outcomes across studies or draw consistent conclusions\u2014which is why the relationship between hormone therapy and glaucoma risk has remained unsettled.<\/p>\n<p>Got it. So how did this study examine the risk?<\/p>\n<p>To move beyond smaller or conflicting datasets, researchers used national health registry data in Finland.<\/p>\n<p>These systems track diagnoses, prescriptions, and healthcare use across large populations, making them useful for long-term risk analysis.<\/p>\n<p>In this case: The study analyzed prescription records and clinical outcomes of a group of postmenopausal women over several decades, allowing investigators to evaluate not just whether patients used HRT, but how long they used it and which hormone types were involved.<\/p>\n<p>Tell me more about these women.<\/p>\n<p>The researchers started with nearly 400,000 women aged 50 and older. After excluding anyone with a prior glaucoma diagnosis or related procedures, they narrowed the cohort down to 6,576 women.<\/p>\n<p>Of those, 1,096 developed glaucoma and were classified as cases. Each case was matched with five controls of the same age, resulting in 5,480 controls.<\/p>\n<p>The researchers also adjusted for key variables like diabetes, statin use, and socioeconomic factors to better isolate the effect of hormone therapy.<\/p>\n<p>What did the data show about HRT and glaucoma risk?<\/p>\n<p>After adjustment, the results were consistent across the board: all forms of hormone therapy were linked to higher glaucoma risk.<\/p>\n<p>Estrogen-only therapy: OR 1.33Progesterone-only therapy: OR 1.25Combined therapy: OR 1.19<\/p>\n<p>In other words, regardless of formulation, hormone therapy use was associated with a modest but measurable increase in glaucoma risk.<\/p>\n<p>The same trend held up in subgroup analysis, particularly for primary open-angle glaucoma, where estrogen-only therapy remained significantly associated with increased risk.<\/p>\n<p>How risk varied by hormone type and duration.<\/p>\n<p>One of the more telling findings was how risk changed over time. Longer exposure to estrogen was associated with higher glaucoma risk, suggesting that duration, not just use, matters.<\/p>\n<p>What limitations may affect how we interpret these results?<\/p>\n<p>Even with a large dataset, there are limitations to keep in mind.<\/p>\n<p>First, this is an observational study, meaning it can show association but not prove causation.<\/p>\n<p>Second, glaucoma diagnoses were based on registry data and treatment eligibility rather than standardized clinical testing like visual fields or OCT. That introduces some variability in how cases are defined.<\/p>\n<p>Finally, the study population is specific to Finland, which may limit how broadly the findings apply to more diverse populations or healthcare systems.<\/p>\n<p>Why do these findings differ from earlier research on estrogen?<\/p>\n<p>The authors themselves stopped short of making definitive claims, noting that hormone therapy \u201cmay increase the glaucoma risk\u201d while emphasizing that further research is needed to confirm the association.<\/p>\n<p>That cautious tone is echoed in clinical coverage. Essentially, the findings are notable because they contradict earlier assumptions about estrogen\u2019s protective role.<\/p>\n<p>At the same time, experts aren\u2019t treating this as a practice-changing conclusion yet. Instead, they\u2019re viewing it as a signal; specifically, one that needs to be interpreted alongside prior research and validated in other populations.<\/p>\n<p>The takeaway from an expert standpoint is measured:<\/p>\n<p>There appears to be an associationBut the underlying mechanism and clinical impact are still not fully understoodWhat does this mean for clinical decision-making moving forward?<\/p>\n<p>This doesn\u2019t mean avoiding hormone therapy altogether. Instead, it adds another factor to consider when evaluating patient risk.<\/p>\n<p>Patients already at higher risk for glaucoma\u2014whether due to age, family history, or vascular disease\u2014may benefit from closer monitoring if they are on long-term HRT.<\/p>\n<p>It also reinforces the importance of routine eye exams in postmenopausal patients, particularly those using hormone therapy over extended periods.<\/p>\n<p>Take home.<\/p>\n<p>This large registry-based study suggests that postmenopausal hormone therapy is associated with an increased risk of glaucoma, regardless of hormone type.<\/p>\n<p>And while the findings don\u2019t change practice overnight, they do shift the conversation. Hormone therapy is no longer just a systemic consideration; it may also be part of the long-term ocular risk profile.<\/p>\n","protected":false},"excerpt":{"rendered":"A recent population-based study published in Acta Ophthalmologica evaluated the potential link between postmenopausal hormone replacement therapy (HRT)&hellip;\n","protected":false},"author":2,"featured_media":515100,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":["post-515099","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/515099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=515099"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/515099\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/515100"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=515099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=515099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=515099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}